BHST
BioHarvest Sciences, Inc.
NASDAQ · Basic Materials · Agricultural Inputs · CA
$1.72
+2.38%Price chart
Sep 24Sep 29Oct 2Oct 7Oct 12Oct 15Oct 20Oct 23
Key dataOct 23, 2026
Open$1.80
From 52W high−85.55%
Volume25346.00
Market cap$38.99M
P/E (TTM)—
P/S (TTM)1.1x
Div yield—
Key dataOct 23, 2026
Open
$1.80
From 52W high
−85.55%
Volume
25346.00
Market cap
$38.99M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−5.5x
P/E (TTM)
—
RSI (14)
48.6
MomentumView details →
1D Return
+2.38%
YTD Return
−68.02%
SummaryUpdated Jun 1, 2026
BioHarvest Sciences Inc. (NASDAQ:BHST) is a Canadian biotechnology company founded to revolutionize how botanical compounds are produced for nutraceutical and pharmaceutical applications. Based in Vancouver, Canada, with operations in Israel and the United States, the company has developed a proprietary botanical synthesis platform that enables the cultivation of plant cells in bioreactors rather than traditional farming methods. Since completing its NASDAQ uplisting in 2024, BioHarvest has positioned itself as both a direct-to-consumer wellness brand and a contract development and manufacturing organization (CDMO) serving pharmaceutical and food industry clients.
Similar companies
Latest newsMore news →
BioHarvest Sciences said Olive Cell, an olive-derived plant-cell ingredient, is ready for commercial licensing after completing large-scale bioreactor scale-up, manufacturing readiness and a self-affirmed U.S. GRAS process.10d agoTate & Lyle Plc and BIOHARVEST SCIENCES INC. announced that their next-generation sweetener development programme demonstrated BioHarvest's Botanical Synthesis platform can produce the targeted sweetening solution.15d ago